Psychedelics (hallucinogenic 5-HT2A agonists such as psilocybin) are being investigated for their potential to treat a range of conditions, including anxiety-related psychopathology. Despite promising...

Psychedelic experiences often evoke a sense of familiarity, an experiential quality that has received little empirical attention despite its potential therapeutic and cognitive significance. This s...

Mapping behavior of individual vertebrate animals across lifespan could provide an unprecedented view into the lifelong process of aging. We created a platform for high-resolution continuous behaviora...

In their recent case report article, Peck and colleagues suggested that two patients recovered dissociated traumatic memories during psilocybin treatment for anorexia nervosa. These case reports are of clinical and scientific interest and confirm that psychedelics may induce vivid memory-like experiences. However, the reports warrant scrutiny. Here, based on what is known about recovered memories and the effects of psychedelics, we argue that the authors may not have adequately considered alternative explanations. The cases do not necessarily demonstrate that psilocybin induces recovery of dissociated traumatic memories or could treat dissociative amnesia. We further caution against the authors’ suggestion of explicitly preparing patients for the emergence of forgotten material.

In the past decade, interest in the effects of psychedelic substances on consciousness, brain function and psychological suffering has grow…

Germany has become the first EU country to allow legal access to psilocybin under a compassionate use program for treatment-resistant depression. Unlike other countries’ pre-approval pathways, Germany...

O artigo de Wolff et al. (2025), "Reframing psychedelic regulation: Tools, not treatments", constitui uma contribuição oportuna e...

A second major EU-funded project in psychedelic science, following PsyPal, will start in the coming months. INTEGRATE will be a doctoral training network supported by €4.3 million in EU funding throug...

Subscription and open access journals from Sage, the world's leading independent academic publisher.

Subscription and open access journals from Sage, the world's leading independent academic publisher.

Psilocybin is a psychedelic serotonergic compound that is renowned for its potent psychoactive effects. Over the past 15 years, an increasing number o…

Clinical psychology has seen a resurgence of interest in the use of psychedelic-assisted therapy (PAT) for the treatment of a range of mental health d…